mibefradil (Cavion)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namemibefradil (Cavion)
Drug Alias Namecalcium T-channel inhibitor (Cavion)calcium T-channel inhibitor (Tau Therapeutics)mibefradilmibefradil (Tau Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated T-type calcium channel blockers
TargetsVoltage-gated T-type calcium channel
Therapy Area/IndicationsGlioblastomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCavion Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCavion Inc
Active IndicationsN/A
Inactive IndicationsGlioblastomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A